UNI-BIO GROUP0690.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, UNI-BIO GROUP (0690.HK) trades at a P/E of 8.24x, P/B of 0.89x, P/S of 0.73x, and a dividend yield of 4.68%.
Longitudinal percentile comparison: P/E sits at the 68th percentile over the trailing 10Y window (vs. 87th percentile over 3Y); P/B sits at the 1st percentile over the trailing 10Y window (vs. 3rd percentile over 3Y); P/S sits at the 8th percentile over the trailing 10Y window (vs. 18th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 31st percentile within its industry and the 38th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 4.68%, ranking at the 94th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 67.3 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. UNI-BIO GROUP operates in the Biomedical II sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 0690 · SEHK: 0690 · 0690
Want the full picture on whether UNI-BIO GROUP (0690.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 8.24 | ||||||
| P/B (MRQ) | 0.89 | ||||||
| P/S (TTM) | 0.73 | ||||||
| Dividend Yield | 4.68% | ||||||
| Buyback + Div Yield | 4.68% |